abstract |
The present invention relates to novel adrenomedullin-based PEG-based prodrugs, to processes for their preparation, to their use for the treatment and / or prophylaxis of diseases and to the treatment and / or prophylaxis of diseases, in particular cardiovascular, edema and / Or for the preparation of medicaments for the prophylaxis. |